Lates News

Daily Economic News reported on September 1st that Minsheng Securities issued a research report giving a buy recommendation for Provecta (603605.SH). The main reasons for the recommendation include: 1) Provecta released its half-yearly report for 2025; 2) steady growth in skincare business and positive performance in online channels; 3) gross profit margin for 2025H1 increased by 3.56% year-on-year to 73.38%, and net profit margin attributable to parent company increased by 0.86% year-on-year; 4) the main brand Provecta continues to deepen its brand strength, while other brands are actively promoted.